NBIXNeurocrine Biosciences, Inc.
NBIX
Neurocrine Biosciences, Inc.3,277
Mkt Cap
$13.07BVolume
395,901.0052W High
$160.1852W Low
$104.42PE Ratio
27.89NBIX Fundamentals
Price
$128.10Prev Close
$130.19Open
$130.1850D MA
$130.10Beta
0.75Avg. Volume
994,323.26EPS (Annual)
$4.67P/B
4.01Rev/Employee
$1.43M$13,528.48
Ruffer LLP Invests $2.48 Million in Neurocrine Biosciences, Inc. $NBIX
Ruffer LLP purchased a new position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the...
MarketBeat·1d ago
Zurcher Kantonalbank Zurich Cantonalbank Boosts Stock Position in Neurocrine Biosciences, Inc. $NBIX
Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 44.7% during the 4th quarter, according to its most recent filing with the...
MarketBeat·1d ago
Neurocrine Biosciences Presents New Two-Year CRENESSITY (crinecerfont) Data Showing Sustained Glucocorticoid Dose Reductions While Maintaining Androgen Control in Adults with Classic Congenital Adrenal Hyperplasia
Neurocrine Biosciences Presents New Two-Year CRENESSITY (crinecerfont) Data Showing Sustained Glucocorticoid Dose Reductions While Maintaining Androgen Control in Adults with Classic Congenital...
PR Newswire·2d ago
Neurocrine Biosciences (NASDAQ:NBIX) Price Target Raised to $170.00
Leerink Partners raised their target price on Neurocrine Biosciences from $160.00 to $170.00 and gave the stock an "outperform" rating in a research note on Wednesday...
MarketBeat·2d ago
Belpointe Asset Management LLC Acquires Shares of 9,485 Neurocrine Biosciences, Inc. $NBIX
Belpointe Asset Management LLC acquired a new stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 9,485 shares of the company's stock, valued at appr...
MarketBeat·2d ago
3 Reasons Growth Investors Will Love Neurocrine (NBIX)
Neurocrine (NBIX) possesses solid growth attributes, which could help it handily outperform the market.
Zacks·3d ago
Wall Street Analysts Think Neurocrine (NBIX) Could Surge 38.79%: Read This Before Placing a Bet
The consensus price target hints at a 38.8% upside potential for Neurocrine (NBIX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·3d ago
KBC Group NV Has $4.60 Million Stock Holdings in Neurocrine Biosciences, Inc. $NBIX
KBC Group NV boosted its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 122.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 32,401 shares of the company's stock after...
MarketBeat·4d ago
Fortis Capital Advisors LLC Invests $1.35 Million in Neurocrine Biosciences, Inc. $NBIX
Fortis Capital Advisors LLC bought a new position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) during the fourth quarter, according to its most recent disclosure with the...
MarketBeat·4d ago
Cwm LLC Purchases 11,306 Shares of Neurocrine Biosciences, Inc. $NBIX
Cwm LLC boosted its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 13.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 95,030 shares of the company's stock after acquiring a...
MarketBeat·5d ago
<
1
2
...
>